Durect Corporation (DRRX) - Product Pipeline Analysis, 2013 Update: New Research Report Available at Fast Market Research
DURECT Corporation (Durect) is a pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. Currently, the company markets two products, namely, Alzet osmotic pump and Lactel biodegradable polymer. The company's product pipeline consists of several investigational drug candidates in clinical development. Durect has five drug delivery technology platforms: SABER, CLOUD, ORADUR, TRANSDUR and DURIN biodegradable implant. The company...
View full press release